Newville Whistleblower Case Leads To $6.2 Million Recovery; Defendant CEO Faces One Year In Prison

(Madison, WI, October 27, 2016)—A stipulation based on a criminal plea deal and a monetary settlement was filed today to resolve a healthcare fraud case involving a western Wisconsin laboratory. The case, United States of America, et al., ex rel. Danielle Ailts Campeau v. NeuroScience, Inc., et al., 13-811 (W.D. Wis.), was filed three years ago by Attorney Joshua Newville on behalf of client Danielle Ailts Campeau.

In October 2013, Newville and Campeau contacted the FBI and the Department of Health and Human Services regarding Osceola, WI-based defendants Pharmasan Labs, Inc., NeuroScience, Inc., and Gottfried Kellermann (the founder and owner of the companies). Ms. Campeau alleged that the defendants were committing fraud on the United States and on the States of Wisconsin, Minnesota, and New York by selling illegitimate laboratory testing services, reporting illegitimate test results, and then using those baseless tests and test results to sell nutritional supplements under a different business name.

Newville subsequently filed, under seal, the lawsuit that led to the settlement and criminal plea deal outlined today. After three years of working with various federal agencies to investigate and prosecute the case, Ms. Campeau now joins the government in requesting that the case be resolved pursuant to stipulation.

The stipulation comes after NeuroScience and owner Gottfried Kellermann pleaded guilty earlier this month. As part of the settlement agreement, which was attached to the filing of today’s stipulation, the